View, browse and sort the list of CPhI North America Conference sessions and show floor programming by pass type, track, and format. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

Detecting Potential Formulation Roadblocks in Early Drug Development


Rita Peters (Editorial Director, Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International, UBM plc)


Ronald D. Snee, Ph.D. (Founder and President, Snee Associates, LLC)

Stephen Tindal (Director of Science Affairs, Catalent Pharma Solutions)

Location: 119A

Date: Tuesday, April 24

Time: 9:45am - 10:30am

Pass Type: Conference Pass, VIP Attendee - Get your pass now!

Track: Drug Development

Vault Recording: TBD

Catalent Pharma Solutions

Getting a compound to clinic is a milestone in the development of a drug. However, formulation hurdles or cost-prohibitive manufacturing challenges detected in later development stages can delay—or derail—the development and approval of a promising compound. Can the odds for getting a drug to market be improved by troubleshooting formulation challenges during early development phases? A panel of experts will review tools, strategies, and methods for assessing the formulation, drug delivery, and manufacturing potential of a drug candidate in preclinical phases. Implications for timelines, API materials, and budgets will be discussed.